Delivery Order SPE2DB22D2206-SPE2DB25FEE41
Award Date
11/12/24
Potential Completion Date
12/4/24
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,796.30 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 5, 2024, with a completion date of June 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.13 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of IBRANCE 75 MG CAPSULE 21S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $15,595.70, has a completion date of July 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering a...
This federal contract award is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,792.08, and has a completion date of November 14, 2024. There is no set-aside designation mentioned for this contract....
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The award has a ceiling value of $8,123.96 and a completion date of May 30, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. AmerisourceBergen Drug...
This federal contract award is for the delivery of IBRANCE 125 MG CAPSULE 21S medical supplies to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract, valued at $15,584.16, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with a completion date of September 24, 2024. It is not designated as a set-aside contract. Amerisourcebergen has been awarded...
This federal contract award, valued at $16,131.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The U.S. Defense Logistics Agency (DLA) awarded a $7,797.84 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to...
This federal contract award is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award, valued at $7,792.08, is a delivery order contract with a firm-fixed price. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract award, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...